Zhibitai Capsules for the Treatment of Primary Hyperlipidemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia — Stella

Home/Primary Hyperlipidemia/

View on ClinicalTrials.gov

Recruiting

Back to Primary Hyperlipidemia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Xiangya Second Hospital of Central South University, Changsha, Hunan

Key details

Phase

Safety & dosing

Sponsor

Chengdu Diao Jiuhong Pharmaceutical Factory

Enrollment target

~192 participants

Started

March 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.